CDKN2A and astrocytoma (excluding glioblastoma): When IDH-mutated astrocytomas and oligodendrogliomas without known CDKN2A/B homozygous deletion were analyzed together (n=157), age did not significantly affect the hazard ratio for overall survival in univariable analysis (p=0.12).